The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...
A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...
OCONTO (WLUK) – Chelsea O’Donnell was ordered Tuesday to stand trial on drug possession counts in one of the two counties ...
The US Food and Drug Administration (FDA) sometimes allows cancer drugs with accelerated approvals to remain on the ...
Second, 23ME-01473 is being studied in a phase 1 trial of people with advanced solid tumors. The dual-mechanism drug ...
The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback